Glenmark Pharmaceuticals Limited (GLENMARK) Share Analysis
NSE · Healthcare · Pharmaceuticals
Glenmark Pharmaceuticals Limited (NSE: GLENMARK) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 200, NIFTY 500, NIFTY Healthcare Index. As of 21 Sep 2026, the share price was ₹2,447.00, market capitalisation ₹69,072 Cr, P/E 22.1, ROE 23.6%.
Get the AI verdict on GLENMARK: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
GLENMARK price and valuation
- Share price
- ₹2,447.00
- Market cap
- ₹69,072 Cr
- P/E ratio
- 22.1
- P/B ratio
- 6.58
- EPS
- ₹63.71
- Book value per share
- ₹372.00
- Dividend yield
- 0.2%
GLENMARK profitability and growth
- ROE
- 23.6%
- ROCE
- 39.8%
- Debt to equity
- 0.06
- Revenue growth (3 yr)
- 14%
- Revenue growth (5 yr)
- 9%
- Profit growth (3 yr)
- 61%
- Profit growth (5 yr)
- 19%
GLENMARK 52-week range
- 52-week high
- ₹2,537.60
- 52-week low
- ₹1,792.60
- Face value
- ₹1.00
GLENMARK shareholding pattern
- Promoters
- 46.65%
- FIIs
- 20.89%
- DIIs
- 18.6%
- Public
- 13.81%
Index membership: NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Midcap 100, NIFTY Midcap 150, NIFTY MidSmallcap 400, NIFTY Pharma, NIFTY Quality 30.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.